KD Pharma’s new Global General Counsel: “Kees” Van Ophem
As of February 2025, Cornelis “Kees”Van Ophem (pictured) joined KD Pharma Group’s management team as their new Global General Counsel & Secretary to the Board.
Alongside these new responsibilities, he continues as Chairman of the Supervisory Board at ipQuants AG.
Van Ophem’s previous experiences include nearly a decade as Executive Vice President and Global General Counsel at Fresenius Medical Care (2015–2024), as well as leadership roles at Leica, where he served as General Counsel & VP and President of Leica Microsystems Schweiz (2010–2015).
The company
Bioggio-based KD Pharma group comprises the omonymous KD Pharma, as well as KD Biopharma, KD Nutra, KD Phyto, and KD LabService, a vertically integrated organization that provides products and services to the pharmaceutical, biotech, and nutrition sectors.
